List view / Grid view

Steven G Jarvis

 

article

Expert view: Managing the complexity of finding new targets and drugging the undruggable

Assessing targets that are unable – or rather, extremely difficult…

5 September 2018 | By

Assessing targets that are unable – or rather, extremely difficult – to reach pharmacologically, has prevented researchers from achieving desired clinical successes, most notably in the realm of cancer research. However, many advances are being made to shedlight on these difficult yet desirable target areas.

article

Expert view: Effective coupling of assays and cell models

Assay robustness tends to be the favoured descriptor when a…

11 September 2017 | By

Assay robustness tends to be the favoured descriptor when a particular assay can cope with minute changes in the sample, equipment, or operator. The more robust an assay, the more predictive data it ultimately yields. The industry’s greatest challenge for assay development has always been using those robust assays to…